{
    "Trade/Device Name(s)": [
        "KeyPath\u2122 MRSA/MSSA Blood Culture Test-BT"
    ],
    "Submitter Information": "MicroPhage, Inc.",
    "510(k) Number": "K120563",
    "Predicate Device Reference 510(k) Number(s)": [
        "K102342"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "OUS"
    ],
    "Summary Letter Date": "February 24, 2012",
    "Summary Letter Received Date": "February 24, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.2050"
    ],
    "Regulation Name(s)": [
        "Staphylococcal typing bacteriophage"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Staphylococcus aureus",
        "Methicillin resistance (MRSA)",
        "Methicillin susceptibility (MSSA)"
    ],
    "Specimen Type(s)": [
        "Positive blood culture"
    ],
    "Specimen Container(s)": [
        "BD BACTEC\u2122 blood culture bottles (Plus Aerobic/F, Plus Anaerobic/F, Standard/10 Aerobic/F, Standard Anaerobic/F)"
    ],
    "Instrument(s)/Platform(s)": [
        "KeyPath\u2122 Detector"
    ],
    "Method(s)/Technology(ies)": [
        "Bacteriophage amplification",
        "Immunoassay"
    ],
    "Methodologies": [
        "Phenotypic resistance testing"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Reagent",
        "Detector",
        "Tube"
    ],
    "Document Summary": "FDA 510(k) summary for KeyPath\u2122 MRSA/MSSA Blood Culture Test-BT for rapid identification and resistance determination of S. aureus directly from positive blood cultures using bacteriophage amplification.",
    "Indications for Use Summary": "Qualitative in vitro diagnostic test for identification of Staphylococcus aureus and determination of methicillin susceptibility (MSSA) or resistance (MRSA) directly from positive blood cultures, performed in conjunction with other laboratory and clinical data.",
    "fda_folder": "Microbiology"
}